Pharmaceutical News

RSS
Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Technological solutions for improving medication adherence

Technological solutions for improving medication adherence

Atogepant may decrease the risk of developing rebound headache in people with migraine

Atogepant may decrease the risk of developing rebound headache in people with migraine

NCCN survey reveals ongoing shortages in crucial cancer medications

NCCN survey reveals ongoing shortages in crucial cancer medications

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

3D drug printers could help personalize medications in the future

3D drug printers could help personalize medications in the future

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

Study reveals high rates of aspirin use for CVD prevention among older adults

Study reveals high rates of aspirin use for CVD prevention among older adults

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Semaglutide weight loss results linked to diabetes severity

Semaglutide weight loss results linked to diabetes severity

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

WEHI spinout aims to revolutionize the development of cancer drugs

WEHI spinout aims to revolutionize the development of cancer drugs

WHO issues medical product alert on falsified semaglutides

WHO issues medical product alert on falsified semaglutides

Enlarged prostate medications may also decrease the risk for dementia with Lewy bodies

Enlarged prostate medications may also decrease the risk for dementia with Lewy bodies

Angiotensin receptor blockers found to lower epilepsy risk, new study reveals

Angiotensin receptor blockers found to lower epilepsy risk, new study reveals

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.